Fingerprint
Dive into the research topics of 'The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The majority of patients with metastatic melanoma are not represented in pivotal phase III immunotherapy trials
Marco Donia, Marie Louise Kimper-Karl, Katrine Lundby Høyer, Lars Bastholt, Henrik Schmidt, Inge Marie Svane